Despite recording a net loss of $26.6m for the second quarter of 2020, ADVANZ PHARMA Corp. Limited’s revenue rose by 1% or $0.8m to $132m compared with the corresponding period of 2019. Advanz also saw a $2m sequential increase in revenue, compared to the first quarter of 2020. The revenue increase was driven by new acquisitions.
Graeme Duncan, CEO & director of Advanz, said the results for the first half of 2020 exceeded the company’s expectations....




